Page last updated: 2024-10-16

carbamates and Epstein-Barr Virus Infections

carbamates has been researched along with Epstein-Barr Virus Infections in 1 studies

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zaunders, JJ1
Kaufmann, GR1
Cunningham, PH1
Smith, D1
Grey, P1
Suzuki, K1
Carr, A1
Goh, LE1
Cooper, DA1

Other Studies

1 other study available for carbamates and Epstein-Barr Virus Infections

ArticleYear
Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.
    The Journal of infectious diseases, 2001, Mar-01, Volume: 183, Issue:5

    Topics: Adult; Anti-HIV Agents; Carbamates; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleos

2001